New to Emory?

If you are a new investigator at Emory, we encourage you to make an appointment with the IRB to take stock of your studies and prepare a plan for a smooth transfer of your research projects. Please visit the About page for general contact information and a list of IRB staff, or send us an email at

ORA Calendar

What's New at the IRB?

Webinar on Screening Procedures:
The Limits of HIPAA Waivers

On March 12 at 12:00 pm (Noon), the Emory IRB will deliver a concise webinar to provide guidance on screening procedures, specifically which activities are covered under a partial HIPAA waiver and which are not.  The presentation will be about 20-30 minutes long with a live question and answer session afterwards.  A link to the live webinar, as well as recordings of each webinar, are available on the Webinars page.

Join the IRB Team!

The Emory IRB is excited to announce the opportunity to join our team!  There are currently two positions posted; one for a Research Protocol Analyst and one for an Analyst Assistant.  To view details about the positions, you may access the Emory Careers database HERE, then go to "search positions," and use the following requisition IDs to go directly to the descriptions.  Research Protocol Analyst (49345BR); Analyst Assistant (49516BR).  

If you have any questions, please feel free to contact the IRB main office.

Condensed Meeting Schedules Nov-Jan

Please see our adjusted holiday meeting schedule.  The IRB will have condensed meeting schedules during the months of November, December, and January.  If you have a study that will be expiring during this time period, we highly recommend that you submit a Continuing Review early to ensure ample time for our evaluation and approval.  If you have any questions or concerns, please feel free to contact us.

New Guidance for Drug/Device Studies

The IRB has created new guidance documents for investigators working with FDA regulated products. These documents, which may be found on the New Submission Guidance page, cover in vitro diagnostic devices, Emory sponsor-investigators, and expanded access use of drugs and devices.

More details and archived items on the News page